Allan S. Wagman

Glycogen Synthase Kinase-3 Regulates Mitochondrial Outer Membrane Permeabilization and Apoptosis by Destabilization of MCL-1

Ulrich Maurer, Céline Charvet, Allan S. Wagman et al. · Molecular Cell · 2006 · 872 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo

David B. Ring, Kirk W. Johnson, Erik J. Henriksen et al. · Diabetes · 2003 · 555 citations · Full text

Life Sciences, Biochemistry, Endocrinology +15

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer

Matthew T. Burger, Sabina Pecchi, Allan S. Wagman et al. · ACS Medicinal Chemistry Letters · 2011 · 251 citations · Full text

Pharmacy, Oncology, Pharmacology +13

Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor

Jérôme Ruzzin, Allan S. Wagman, Jørgen Jensen · Diabetologia · 2005 · 240 citations · Full text

Life Sciences, Endocrinology, Physiology +17

The Total Synthesis of (±)-Ginkgolide B

Michael T. Crimmins, Jennifer M. Pace, Philippe G. Nantermet et al. · Journal of the American Chemical Society · 2000 · 105 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16